Stockreport

Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476M [Seeking Alpha]

ArriVent BioPharma, Inc.  (AVBP) 
PDF Suzhou Alphamab Oncology partners with ArriVent BioPharma to develop antibody drug conjugates, potentially receiving up to $615.5 million in milestones. Summit Therap [Read more]